in the press

Apr 19, 2021

Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program

From magic mushrooms to ketamine, psychedelic drugs are having a serious heyday across the planet. Currently seeing considerable interest and acceptance by the public to treat emotional distress, the so-called third wave of psychedelics is cresting. And with that swelling attention is the creation of the essential machinery to support the new medical model — including consistent protocols and training preparation for clinicians.

Apr 5, 2021

Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction

Amber Capone had become afraid of her husband. The “laid-back, bigger than life and cooler than cool” man she’d married had become isolated, disconnected and despondent during his 13 years as a U.S. Navy SEAL. Typically, he was gone 300 days of the year, but when he was home, Amber and their two children walked on eggshells around him. “Everyone was just playing nice until he left again,” Amber says.

Mar 21, 2021

As More People Turn To Psychedelics, Integration Proves A Crucial Factor For Breakthroughs ‍

Nick Watchorn had suffered for most of his adult life from severe post-traumatic stress disorder (PTSD) before he sought psychedelic treatments to deal with his chronic condition. He credits those psychoactive sessions, and particularly the work he did afterwards in a process known as integration — a way of gleaning insights from the experience — with saving his life. “I thought I was too far gone,” he says of himself before receiving therapeutic treatments using MDMA-assisted therapy (aka ecstasy).


More Videos

The Need for Psychedelic Integration in Clinical Settings at Colloquium on Psychedelic Psychiatry 2018 (Dr. Elizabeth Nielson)

A Case for Research on Psychedelic Therapists’ First-hand Experience on Psychedelics (Horizons, NYC, 2017)

Psilocybin-Assisted Treatment of Alcohol Use Disorder (Karolinska Institute, Stockholm, 2019)

Psilocybin-Assisted Treatment of Alcohol Use Disorder (In-Sight Conference, Berlin, 2019)

What Is The Latest In Psychedelic Research Telling Us?

Horizons 2018: Ingmar Gorman, PH.D. & Willa Hall, PH.D. “MDMA-Assisted Clinical Study of PTSD”


ACISTE Community Conversation on Psychedelics with Drs. Ingmar Gorman, Alexander Belser, & Richard Knowles.

How to get Involved with Psychedelic Research with Dr. Ingmar Gorman on the Psychedelics Today Podcast

Psychedelics & Psychotherapy with Dr. Ingmar Gorman on the Empowering Neurologist

The Psychedelic Renaissance with Dr. Ingmar Gorman and Dr. Elizabeth Nielson on the MindSpace Podcast

Curating an Optimal Psychedelic Experience with Dr. Ingmar Gorman and Dr. Elizabeth Nielson on the Third Wave Podcast

Microdosing with Caution with Dr. Ingmar Gorman on the Third Wave Podcast